Showing 1321 to 1340 of 3449 bills
| Bill Title | Introduced | Latest Action |
|---|---|---|
|
HF 2680
(Minnesota - 2023-2024 Regular Session)
Commerce finance and policy bill. |
Mar 08 2023 |
Committee Report, To Adopt As Amended And Re-Refer To Ways And Means
Apr 12 2023 |
|
HB 1271
(Arkansas - 2023 Regular Session)
To Amend The Prior Authorization Transparency Act; And To Exempt Certain Healthcare Providers That Provide Certain Healthcare Services From Prior Authorization Requirements. |
Jan 26 2023 |
Notification That Hb1271 Is Now Act 575
Apr 11 2023 |
|
HF 525
(Iowa - 2023-2024 Regular Session)
A bill for an act relating to the Medicaid program including third-party recovery and taxation of Medicaid managed care organization premiums. |
Mar 01 2023 |
Withdrawn.
Apr 11 2023 |
|
SF 462
(Iowa - 2023-2024 Regular Session)
A bill for an act relating to the Medicaid program including third-party recovery and taxation of Medicaid managed care organization premiums. |
Feb 28 2023 |
Committee Report Approving Bill, Renumbered As Sf 567.
Apr 10 2023 |
|
SB 2378
(North Dakota - 68th Legislative Assembly (2023-24))
AN ACT to create and enact a new section to chapter 19-02.1 of the North Dakota Century Code, relating to clinician-administered drugs. |
Jan 23 2023 |
Filed With Secretary Of State 04/05
Apr 07 2023 |
|
H 215
(Idaho - 67th Legislature, 1st Regular Session (2023))
INSURANCE – Amends existing law to provide for enforcement of provisions applicable to pharmacy benefit managers. |
Feb 24 2023 |
Reported Signed By Governor On March 31, 2023 Session Law Chapter 232 Effective: 07/01/2023
Apr 06 2023 |
|
H 291
(Idaho - 67th Legislature, 1st Regular Session (2023))
FAIR PHARMACY AUDITS ACT – Adds to existing law to implement the Fair Pharmacy Audits Act. |
Mar 09 2023 |
Reported Signed By Governor On March 31, 2023 Session Law Chapter 233 Effective: 07/01/2023
Apr 06 2023 |
|
SB 124
(Alaska - 33rd Legislature (2023-2024))
An Act relating to health care insurers; relating to pharmacy benefits managers; relating to prescription drug defined cost sharing; and providing for an effective date. |
Apr 05 2023 |
(S) Referred To Labor & Commerce
Apr 05 2023 |
|
HB 6159
(Rhode Island - 2023 Regular Session)
AN ACT RELATING TO INSURANCE -- PRESCRIPTION DRUG BENEFITS (Includes any costs paid by an enrollee or on behalf of the enrollee by a third party when calculating an enrollee’s overall contribution to any out-of-pocket maximum or cost sharing requirement under a health plan as of January 1, 2024.) |
Mar 17 2023 |
04/05/2023 Committee Recommended Measure Be Held For Further Study
Apr 05 2023 |
|
SB 106
(Rhode Island - 2023 Regular Session)
AN ACT RELATING TO INSURANCE -- CONTROL OF HIGH PRESCRIPTION COSTS -- REGULATION OF PHARMACY BENEFIT MANAGERS (Regulates PBMs policies and practices relating to accurate costs and pricing reporting, restricts discriminatory practices and establishes consumer protections and enforcement of penalties for violations by the office of the attorney general.) |
Feb 01 2023 |
04/04/2023 Committee Recommended Measure Be Held For Further Study
Apr 04 2023 |
|
S 1130
(United States - 118th Congress)
Health Care PRICE Transparency Act |
Mar 30 2023 |
Introduced In Senate
Mar 30 2023 |
|
S 1131
(United States - 118th Congress)
Drug Price Transparency Act of 2023 |
Mar 30 2023 |
Introduced In Senate
Mar 30 2023 |
|
HB 3761
(Illinois - 103rd Regular Session)
Ins-Pbm/Duties & Prohibitions |
Feb 17 2023 |
Added Co-Sponsor Rep. Christopher "C.D." Davidsmeyer
Mar 30 2023 |
|
HB 1713
(Oklahoma - 2023 Regular Session)
Pharmacies; definitions; requirements; penalties; codification; emergency. |
Feb 06 2023 |
Second Reading Referred To Health And Human Services
Mar 30 2023 |
|
HB 2351
(Oklahoma - 2023 Regular Session)
Health insurance; definitions; treatment of diabetes; Insurance Department and the State Department of Health to purchase insulin at discounted prices; program that allows Oklahomans to purchase discounted insulin; codification; effective date. |
Feb 06 2023 |
Referred To Rules
Mar 30 2023 |
|
HB 53
(New Mexico - 2023 Regular Session)
Delivery Of Necessary Diabetic Resources |
Jan 10 2023 |
Signed
Mar 30 2023 |
|
S 1038
(United States - 118th Congress)
Drug Price Transparency in Medicaid Act of 2023 |
Mar 29 2023 |
Introduced In Senate
Mar 29 2023 |
|
HB 417
(Georgia - 2023-2024 Regular Session)
Insurance; prohibit insurers from discriminating against certain healthcare facilities and providers in connection with provider administered drugs |
Feb 15 2023 |
House Withdrawn, Recommitted
Mar 29 2023 |
|
HB 1245
(Illinois - 103rd Regular Session)
Dpt Returning Resident Affairs |
Jan 18 2023 |
Rule 19(A) / Re-Referred To Rules Committee
Mar 27 2023 |
|
SF 168
(Minnesota - 2023-2024 Regular Session)
Excessive price increases by manufacturers prohibition to generic or off-patent drugs |
Jan 11 2023 |
Comm Report: To Pass As Amended And Re-Refer To Judiciary And Public Safety
Mar 27 2023 |
Showing 1321 to 1340 of 3449 bills
